EB
Elucid Bioimaging Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$36.5Msold at filing
Total offering$80M$43.5M still open
Investors in the raise9count reported to the SEC
FiledOct 22, 2025first sale Oct 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Evan MelroseDirector
Michael LeshDirector
Blake RichardsExecutive Officer
Richard KuntzDirector
Rajesh PandaDirector
Kelly HuangExecutive Officer, Director
Shamiram FeinglassDirector
Scott HuennekensDirector
Executive officers, directors and promoters as listed on the Form D.